ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Connecticut » Psychiatry

Top Psychiatry Prescribers in Connecticut

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HENRY CRABBE MD

Psychiatry

1,428

$276K

95
24 are 65+

17%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

34%
prescriptions for brand name drugs

Avg: 24%

$193
Average prescription price

Avg: $130

MARK LIGORSKI MD

Psychiatry

1,422

$266K

94
51 are 65+

14%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$187
Average prescription price

Avg: $130

DIANA STANCOV MD

Psychiatry

1,339

$139K

101
46 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

24%
prescriptions for brand name drugs

Avg: 24%

$103
Average prescription price

Avg: $130

SCOTT WOODS MD

Psychiatry

1,328

$184K

95
29 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$139
Average prescription price

Avg: $130

DEBORAH SCHROTER M. D.

Psychiatry

1,326

$176K

62
32 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

26%
prescriptions for brand name drugs

Avg: 24%

$132
Average prescription price

Avg: $130

MARIA PATRASCU MD

Psychiatry

1,316

$223K

48
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$170
Average prescription price

Avg: $130

JOSEPH WILLIAMS M.D.

Psychiatry

1,307

$255K

117
36 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

31%
prescriptions for brand name drugs

Avg: 24%

$195
Average prescription price

Avg: $130

ROBERT GRILLO M.D.

Psychiatry

1,289

$147K

97
74 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$114
Average prescription price

Avg: $130

DONNA KLIMOWICZ M.D.

Psychiatry

1,287

$180K

73
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$140
Average prescription price

Avg: $130

MICHAEL VOLLMAR MD

Psychiatry

1,287

$232K

66
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

28%
prescriptions for brand name drugs

Avg: 24%

$180
Average prescription price

Avg: $130

ERUM SHAHAB MD

Psychiatry

1,285

$265K

78
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

38%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

58%
prescriptions for brand name drugs

Avg: 24%

$207
Average prescription price

Avg: $130

BARBARA ORROK M.D.

Psychiatry

1,284

$134K

77
23 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $130

JUDITH CARLSON MD

Psychiatry

1,271

$182K

71
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$143
Average prescription price

Avg: $130

GARY PLOTKE M.D.

Psychiatry

1,265

$147K

97
19 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$116
Average prescription price

Avg: $130

SUDHA SREENIVASAN MD

Psychiatry

1,263

$149K

103
21 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

21%
prescriptions for brand name drugs

Avg: 24%

$118
Average prescription price

Avg: $130

LAURENCE GOLDSTEIN MD

Psychiatry

1,262

$122K

97
62 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$97
Average prescription price

Avg: $130

MOON HEE YOO M.D.

Psychiatry

1,249

$189K

69
0 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$151
Average prescription price

Avg: $130

GHAZI ASAAD M.D.

Psychiatry

1,224

$191K

106
72 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$156
Average prescription price

Avg: $130

ROSALBA SALAMANCA MD

Psychiatry

1,224

$219K

81
20 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

23%
prescriptions for brand name drugs

Avg: 24%

$179
Average prescription price

Avg: $130

CHRISTINE NAUNGAYAN MD

Psychiatry

1,162

$154K

69
18 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

25%
prescriptions for brand name drugs

Avg: 24%

$133
Average prescription price

Avg: $130

CHARLES RIORDAN MD

Psychiatry

1,157

$122K

79
30 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

18%
prescriptions for brand name drugs

Avg: 24%

$105
Average prescription price

Avg: $130

DANIEL MOORE MD

Psychiatry

1,156

$104K

107
60 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

22%
prescriptions for brand name drugs

Avg: 24%

$90
Average prescription price

Avg: $130

PETER MOHRER M.D.

Psychiatry

1,146

$140K

115
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

27%
prescriptions for brand name drugs

Avg: 24%

$122
Average prescription price

Avg: $130

JOOSUB ESSACK M.D.

Psychiatry

1,135

$134K

107
47 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

17%
prescriptions for brand name drugs

Avg: 24%

$118
Average prescription price

Avg: $130

FREDERICK REINDEL MD

Psychiatry

1,116

$119K

80
34 are 65+

0%
patients receiving schedule two controlled substances

Avg: 2%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 2%

19%
prescriptions for brand name drugs

Avg: 24%

$107
Average prescription price

Avg: $130

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank